Treatment of extensively drug-resistant tuberculosis.
Aggarwal
Deepak
D
Mohapatra
Prasanta R
PR
Janmeja
Ashok K
AK
D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001372:Aza Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy*; D024841:Fluoroquinolones; D006801:Humans; D000069349:Linezolid; D000077266:Moxifloxacin; D023303:Oxazolidinones / Q000008:administration & dosage / Q000627:therapeutic use*; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use*
D000081:Acetamides; D000890:Anti-Infective Agents; D000995:Antitubercular Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D023303:Oxazolidinones; D011804:Quinolines; D000069349:Linezolid; D000077266:Moxifloxacin